GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ARCpoint Inc (TSXV:ARC) » Definitions » Research & Development

ARCpoint (TSXV:ARC) Research & Development : C$0.33 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ARCpoint Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. ARCpoint's Research & Development for the three months ended in Mar. 2024 was C$0.14 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.33 Mil.

ARCpoint Research & Development Historical Data

The historical data trend for ARCpoint's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARCpoint Research & Development Chart

ARCpoint Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
- - - - 0.33

ARCpoint Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.34 0.15 -0.31 0.14

ARCpoint Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARCpoint  (TSXV:ARC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ARCpoint Research & Development Related Terms

Thank you for viewing the detailed overview of ARCpoint's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

ARCpoint (TSXV:ARC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ARCpoint Inc (TSXV:ARC) » Definitions » Research & Development
Comparable Companies
TSX:SZLS TSXV:JUMP XCNQ:IZO XCNQ:VTAL NEOE:MEDV TSXV:MBI.H TSXV:TELO XCNQ:SONA TSXV:AVCR XCNQ:BUX TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH
Traded in Other Exchanges
N/A
Address
101 North Main Street, Suite 301, Greenville, SC, USA, 29601
Website
https://www.arcpointlabs.com
ARCpoint Inc is a US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing, and physician services for ARCpoint franchise labs and other clients.